Aerobic fitness as a modifier of neurodegeneration and cognitive decline in preclinical Alzheimer's disease
有氧健身作为临床前阿尔茨海默病神经退行性变和认知能力下降的调节剂
基本信息
- 批准号:10165451
- 负责人:
- 金额:$ 17.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AD transgenic miceAddressAdultAerobic ExerciseAffectAge of OnsetAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAmyloidAnimal Disease ModelsAnimal ModelAreaBiological MarkersBrainBrain InjuriesBrain PathologyCCL2 geneCardiovascular PathologyCessation of lifeChronicClinicalCognitionColombianData CollectionDementiaDiseaseDisease ProgressionEnsureEpisodic memoryExerciseFamilyFamily memberFunctional Magnetic Resonance ImagingFundingFutureGenesGoalsGoldHealthHumanImageImpaired cognitionIndividualInflammatoryInflammatory ResponseInterleukin-1Interleukin-6InterventionKnowledgeLinkLongitudinal StudiesMagnetic Resonance ImagingMeasuresMemoryMemory LossMentored Patient-Oriented Research Career Development AwardMentorshipModelingMultimodal ImagingMutationNerve DegenerationNeurofibrillary TanglesNeurogliaNeurophysiology - biologic functionParietalParticipantPathologicPathologyPatient Self-ReportPerformancePhysical activityPopulation HeterogeneityPositron-Emission TomographyPrevalenceResearchResearch TrainingRestRoleScientistSenile PlaquesSpinal PunctureSymptomsTechniquesTestingTimeTrainingUniversitiesVO2maxautosomal dominant Alzheimer&aposs diseasebrain healthcareercareer developmentcognitive changecognitive functioncognitive testingcytokinedesignfitnesshealthy agingimaging modalityimprovedin vivoindexingkindredlifestyle factorslongitudinal analysismutation carrierneurogenesisneuroimagingneuroinflammationnovelpre-clinicalpreclinical studypresenilin-1preventrelating to nervous systemresponseskillsstandard measuretau Proteinsβ-amyloid burden
项目摘要
PROJECT SUMMARY / ABSTRACT
The prevalence of Alzheimer's disease (AD) is expected to rise significantly, reaching 15 million
individuals by 2060 in the US. AD-related brain and cognitive changes are evident several years before
symptom onset, in what is known as the preclinical stage. In the absence of disease-modifying treatments, it is
imperative that we identify and characterize lifestyle factors that could modify the course of the disease.
Greater aerobic fitness, objectively measured by VO2max, is considered a critical component of overall health
and a strong predictor of cognitive functioning. It may prevent or modify the progression of AD, as it has been
associated with stronger functional brain functioning and less amyloid and tau burden. It has also been shown
to reduce neuroinflammation, which further contributes to disease progression and cognitive decline. While
there is considerable evidence supporting the benefits of greater fitness in healthy aging, less is known about
how it impacts the progression of AD. Specifically, there is paucity of research investigating, 1) the relation of
fitness to AD-related brain pathology and functional connectivity; 2) the mechanisms that underlie the
relationship between fitness and memory functioning in AD; and 3) changes in AD-related brain pathology,
brain functioning and cognition associated with fitness overtime.
The candidate will capitalize on an ongoing NIA-funded observational longitudinal biomarker study with a
Colombian kindred with autosomal-dominant AD (ADAD), the world's largest family with a single mutation
(E280A) in the Presenilin-1 gene that leads to dementia. She will test the hypothesis that greater aerobic
fitness is associated with better brain functioning, less accumulation of brain pathology (tau and amyloid), and
less neuroinflammation in presymptomatic mutation carriers. Some consider that ADAD is the ideal model to
study preclinical changes associated with AD since mutation carriers, who are otherwise healthy (e.g. no
cardiovascular pathology), will invariably develop dementia. Thus, this provides the opportunity to investigate
the direct link between AD and aerobic fitness. To test the hypotheses, each participant will undergo PET
PiB (amyloid) and 18F T807 (tau), functional MRI at rest, cognitive testing, and lumbar puncture to examine
neuroinflammation as measured by a composite index of neuroinflammatory markers, at baseline and every
24 months. The candidate will obtain training in, (1) assessing aerobic fitness and understanding its relation to
brain health, (2) longitudinal analytic approaches, (3) multimodal imaging methods, and (4) assessing and
understanding the role of neuroinflammation in preclinical AD. She has gathered an exceptional team of
experts in aging and AD from the MGH, Harvard University and Northeastern University, who are fully
committed to helping her accomplish her research training and career development goals, as well as to ensure
her successful transition to an independent and productive career in aging research.
项目总结/摘要
阿尔茨海默病(AD)患病率预计将大幅上升,达到1500万人
到2060年,在美国。AD相关的大脑和认知变化在几年前就很明显了
症状发作,即所谓的临床前阶段。在缺乏疾病修饰治疗的情况下,
我们必须确定和描述可能改变疾病进程的生活方式因素。
更好的有氧健身,通过VO 2 max客观测量,被认为是整体健康的关键组成部分
也是认知功能的重要预测指标它可以阻止或改变AD的进展,因为它已经
与更强的功能性脑功能和更少的淀粉样蛋白和tau蛋白负荷相关。还已经表明
以减少神经炎症,这进一步有助于疾病进展和认知能力下降。而
有相当多的证据支持健康老龄化中更大的健身益处,但对
如何影响AD的进展。具体而言,缺乏研究调查,1)
适应AD相关的大脑病理和功能连接; 2)基础的机制,
AD中健康和记忆功能之间的关系;和3)AD相关脑病理学的变化,
大脑功能和认知与健身超时。
候选人将利用正在进行的由NIA资助的观察性纵向生物标志物研究,
哥伦比亚亲属患有常染色体显性AD(ADAD),这是世界上最大的单一突变家族
(E280 A)在早老素-1基因,导致痴呆症。她将检验更好的有氧运动的假设
健康与更好的大脑功能,更少的大脑病理(tau蛋白和淀粉样蛋白)积累有关,
症状前突变携带者的神经炎症较少。有些人认为ADAD是理想的模型,
研究与AD相关的临床前变化,因为突变携带者在其他方面是健康的(例如,
心血管病理学),将不可避免地发展成痴呆症。因此,这提供了调查的机会
AD和有氧健身之间的直接联系为了验证假设,每位参与者都将接受PET检查
PiB(淀粉样蛋白)和18F T807(tau),静息时功能性MRI,认知测试和腰椎穿刺检查
通过神经炎症标志物的复合指数测量的神经炎症,在基线和每个
24个月候选人将获得培训,(1)评估有氧健身和理解其关系,
脑健康,(2)纵向分析方法,(3)多模式成像方法,(4)评估和
了解神经炎症在临床前AD中的作用。她组建了一支出色的团队,
来自MGH、哈佛大学和东北大学的老龄化和AD专家,他们完全
致力于帮助她完成她的研究培训和职业发展目标,以及确保
她成功地过渡到一个独立的和富有成效的职业生涯在老龄化研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edmarie Guzmán-Vélez其他文献
Edmarie Guzmán-Vélez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edmarie Guzmán-Vélez', 18)}}的其他基金
Aerobic fitness as a modifier of neurodegeneration and cognitive decline in preclinical Alzheimer's disease
有氧健身作为临床前阿尔茨海默病神经退行性变和认知能力下降的调节剂
- 批准号:
10653824 - 财政年份:2019
- 资助金额:
$ 17.36万 - 项目类别:
Aerobic fitness as a modifier of neurodegeneration and cognitive decline in preclinical Alzheimer's disease
有氧健身作为临床前阿尔茨海默病神经退行性变和认知能力下降的调节剂
- 批准号:
9979722 - 财政年份:2019
- 资助金额:
$ 17.36万 - 项目类别:
Aerobic fitness as a modifier of neurodegeneration and cognitive decline in preclinical Alzheimer's disease
有氧健身作为临床前阿尔茨海默病神经退行性变和认知能力下降的调节剂
- 批准号:
10417118 - 财政年份:2019
- 资助金额:
$ 17.36万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 17.36万 - 项目类别:
Research Grant














{{item.name}}会员




